New Trial to Test Implantable Pacemaker for Serious Depression
(NEW YORK)Researchers at 20 leading medical centers in the US are testing a pacemaker-like device that may ease the symptoms of depression. Cyberonics, Inc., the device manufacturer, is currently awaiting approval form the Food and Drug Administration to begin clinical trials. The implanted device will stimulate a nerve that runs down the side of the neck. The nerve will be stimulated for 30 seconds, stop for 5 minutes, and begin again. Side effects of the stimulation include voice change, a sense that something is in the patient's mouth, and difficulty breathing during vigorous activity. For more information visit www.abcnews.com.
Revolutionizing Hospital Cleanliness: How Color Additives Transform Infection Prevention
December 9th 2024Discover how a groundbreaking color additive for disinfectant wipes improved hospital cleanliness by 69.2%, reduced microbial presence by nearly half, and enhanced cleaning efficiency—all without disrupting workflows.
Splash Pads and Waterborne Disease Outbreaks: A 25-Year Perspective Introduction
December 5th 2024A CDC report reveals 25 years of splash pad-linked waterborne outbreaks, highlighting risks from pathogens like Cryptosporidium. Prevention requires better hygiene, water treatment, and public health strategies.
Piloting Change Management: Tools for Infection Preventionists to Drive Impactful Change
December 5th 2024Infection preventionists play a vital role in health care, leveraging change management techniques to overcome resistance, unite stakeholders, and implement strategies prioritizing patient safety.
